Published in J Virol on October 01, 1987
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol (1989) 3.98
Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J Virol (1993) 3.53
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids. J Virol (1996) 2.28
Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes. J Virol (1996) 2.17
Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination. J Virol (1990) 2.10
Replacement mutagenesis of the human cytomegalovirus genome: US10 and US11 gene products are nonessential. J Virol (1991) 1.96
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J Virol (1996) 1.90
Boundaries and structure of human cytomegalovirus oriLyt, a complex origin for lytic-phase DNA replication. J Virol (1992) 1.76
Multicomponent origin of cytomegalovirus lytic-phase DNA replication. J Virol (1991) 1.58
Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev (2008) 1.50
Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol (2002) 1.48
Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol (1996) 1.13
Human cytomegalovirus UL102 gene. J Virol (1995) 1.07
Human cytomegalovirus induces JC virus DNA replication in human fibroblasts. Proc Natl Acad Sci U S A (1993) 0.92
Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir. Antimicrob Agents Chemother (1991) 0.87
Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction. Am J Pathol (1991) 0.83
The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replication. J Virol (2010) 0.81
Molecular biology of cytomegalovirus. Int J Exp Pathol (1990) 0.77
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. J Virol (1978) 11.19
Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol (1982) 6.20
The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication. Cell (1984) 4.90
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucleic Acids Res (1985) 4.84
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09
Genetic analysis of temperature-sensitive mutants which define the gene for the major herpes simplex virus type 1 DNA-binding protein. J Virol (1983) 3.98
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J (1986) 3.89
Cloning of the complete human cytomegalovirus genome in cosmids. Gene (1982) 3.55
Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun (1982) 3.40
Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology (1984) 3.34
Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc Natl Acad Sci U S A (1986) 3.28
A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1986) 3.24
Covalent attachment of DNA to agarose. Improved synthesis and use in affinity chromatography. Eur J Biochem (1975) 3.18
Nonstructural proteins of herpes simplex virus. II. Major virus-specific DNa-binding protein. J Virol (1981) 3.03
Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. Intervirology (1981) 2.92
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII. J Virol (1982) 2.59
Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus. J Mol Biol (1986) 2.50
The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J Virol (1985) 2.46
Post-transcriptional control of human cytomegalovirus gene expression. Virology (1983) 2.03
Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol (1974) 1.99
Characterization of the major mRNAs transcribed from the genes for glycoprotein B and DNA-binding protein ICP8 of herpes simplex virus type 1. J Virol (1984) 1.99
Interaction with nucleic acids and stimulation of the viral DNA polymerase by the herpes simplex virus type 1 major DNA-binding protein. J Virol (1984) 1.91
Interaction between the DNA polymerase and single-stranded DNA-binding protein (infected cell protein 8) of herpes simplex virus 1. J Biol Chem (1987) 1.86
Human cytomegalovirus DNA: physical maps for restriction endonucleases BglII, hindIII and XbaI. J Gen Virol (1980) 1.84
Expression of a human cytomegalovirus late gene is posttranscriptionally regulated by a 3'-end-processing event occurring exclusively late after infection. Mol Cell Biol (1986) 1.78
Characterization of two conformational forms of the major DNA-binding protein encoded by herpes simplex virus 1. J Virol (1982) 1.75
The major herpes simplex virus DNA-binding protein holds single-stranded DNA in an extended configuration. J Virol (1983) 1.61
Expression of herpes simplex virus type 1 major DNA-binding protein, ICP8, in transformed cell lines: complementation of deletion mutants and inhibition of wild-type virus. J Virol (1987) 1.51
Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci U S A (1985) 1.50
An immunoassay for the study of DNA-binding activities of herpes simplex virus protein ICP8. J Virol (1985) 1.37
Large-scale rearrangement of homologous regions in the genomes of HCMV and EBV. Virology (1987) 1.36
DNA-negative temperature-sensitive mutants of herpes simplex virus type 1: patterns of viral DNA synthesis after temperature shift-up. J Virol (1976) 1.29
Identification and characterization of a major early cytomegalovirus DNA-binding protein. J Virol (1986) 1.14
Comparison of restriction site polymorphisms among clinical isolates and laboratory strains of human cytomegalovirus. J Gen Virol (1986) 1.11
In vitro characterization of a thermolabile herpes simplex virus DNA-binding protein. J Virol (1986) 0.95
Genome variation and evolution among herpes viruses. Ann N Y Acad Sci (1980) 0.87
Experimental studies on the antiherpetic agent phosphonoformic acid. Adv Ophthalmol (1979) 0.77
Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. J Virol (1978) 11.19
Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells. Virology (1977) 8.24
Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments. Proc Natl Acad Sci U S A (1980) 6.66
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun (1980) 5.03
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell (1980) 4.47
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. J Virol (1984) 4.37
Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA. Cell (1982) 4.36
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol (1989) 4.25
Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun (1982) 4.22
Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J Virol (1985) 3.67
NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J (1989) 3.58
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Site-specific inversion sequence of the herpes simplex virus genome: domain and structural features. Proc Natl Acad Sci U S A (1981) 3.45
Herpesvirus-dependent amplification and inversion of cell-associated viral thymidine kinase gene flanked by viral a sequences and linked to an origin of viral DNA replication. Proc Natl Acad Sci U S A (1982) 3.44
Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun (1982) 3.40
A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1986) 3.24
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class. Cell (1986) 3.20
A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A (1996) 3.14
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
Characterization of post-translational products of herpes simplex virus gene 35 proteins binding to the surfaces of full capsids but not empty capsids. J Virol (1984) 2.95
Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol (1992) 2.95
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol (1998) 2.86
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol (1982) 2.71
Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products. Proc Natl Acad Sci U S A (1989) 2.64
Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. J Virol (1982) 2.62
Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol (1991) 2.61
Human cytomegalovirus infection inhibits G1/S transition. J Virol (1997) 2.61
Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology (1984) 2.56
Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol (1985) 2.54
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells. Proc Natl Acad Sci U S A (1981) 2.48
The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J Virol (1985) 2.46
Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1(F) gB gene. Virology (1984) 2.44
Variability in the structural polypeptides of herpes simplex virus 1 strains: potential application in molecular epidemiology. Infect Immun (1976) 2.35
Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol (1988) 2.35
Molecular evolution of herpesviruses: genomic and protein sequence comparisons. J Virol (1994) 2.34
Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1. Virology (1986) 2.29
The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol (1997) 2.24
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol (1979) 2.16
Quantitative analysis of latent human cytomegalovirus. J Virol (1999) 2.11
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen Virol (1995) 2.10
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A (2001) 2.10
Herpes simplex virus envelopment and maturation studied by fracture label. J Virol (1992) 2.10
Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc Natl Acad Sci U S A (1992) 2.09
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology (1993) 2.02
Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet (1995) 2.01
A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods (1986) 1.98
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J Virol (1994) 1.98
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J Virol (1996) 1.90
Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis. J Virol (1986) 1.89
Transactivation of the grp78 promoter by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT motif which interacts with CTF/NF-I. Mol Cell Biol (1991) 1.89
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Cytomegalovirus determinant of replication in salivary glands. J Virol (1992) 1.82
Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol (2000) 1.82
A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol (2001) 1.79
Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 1.76
Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology (1984) 1.76
A method to identify distinctive charge configurations in protein sequences, with application to human herpesvirus polypeptides. J Mol Biol (1989) 1.75
Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infect Immun (1982) 1.71
A DNA helicase induced by herpes simplex virus type 1. Nucleic Acids Res (1988) 1.70
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis (1995) 1.69
Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology (1997) 1.66
Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody. Infect Immun (1983) 1.65
Mapping of functional and antigenic domains of the alpha 4 protein of herpes simplex virus 1. J Virol (1988) 1.63
Herpes simplex virus glycoprotein gA/B: evidence that the infected Vero cell products comap and arise by proteolysis. J Virol (1982) 1.62
Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology (1988) 1.60
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A (1999) 1.53
Herpes simplex virus type 1 recombination: role of DNA replication and viral a sequences. J Virol (1992) 1.52
Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci U S A (1985) 1.50
The cleavage recognition signal is contained within sequences surrounding an a-a junction in herpes simplex virus DNA. Virology (1988) 1.49
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis (1983) 1.47
Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis. J Virol (1987) 1.46
Expression of herpes simplex virus glycoprotein C from a DNA fragment inserted into the thymidine kinase gene of this virus. Proc Natl Acad Sci U S A (1982) 1.45
Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology (1995) 1.44
Nucleotide sequence and structural features of a novel US-a junction present in a defective herpes simplex virus genome. J Virol (1985) 1.44
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med (1998) 1.43
Persistence of the cytomegalovirus genome in human cells. J Virol (1979) 1.39
Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Virology (1992) 1.38
Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl (1995) 1.37
Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol (2001) 1.37
A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence. J Virol (1989) 1.36
Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology (1994) 1.36